ArticleThe journal of vascular access2026
Simultaneous removal and replacement of the peritoneal catheter in PD patients with partial refractory peritonitis.
Article in The journal of vascular access, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In patients on peritoneal dialysis (PD) peritonitis continues to be the main cause of PD-related death, and the leading reason of transfer to hemodialysis (HD). International guidelines recommend that peritoneal catheter should be removed if PD effluent does not clear after 5 days of adequate antibiotics defining the case as refractory peritonitis. The simultaneous removal and replacement of the peritoneal catheter (SCR) has been used as treatment for recurrent or catheter-related peritonitis after the utter healing of the acute infection to spare patient the interruption of PD and the transfer to HD. On the other hand, in case of refractory episodes the employment of SCR is discouraged. However, the clinical trend of refractory peritonitis is not homogenous: some episodes are totally unresponsive to medical therapy, while others show to be partially responsive. Thus, the treatment should be diversified according to the different clinical evolution. We report two cases of refractory peritonitis sustained by P. aeruginosa that were successfully treated by SCR after a partial response to antibiotic therapy. Along with these preliminary data, we propose a novel therapeutical algorithm differentiating between complete refractory peritonitis and partial refractory peritonitis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.